期刊文献+

硝酸酯类一氧化氮供体型姜黄素衍生物的合成

Synthesis of Nitrate NO Donor Curcumin Derivatives
下载PDF
导出
摘要 为寻找活性更高的药物,根据前药原理和拼合原理将姜黄素与硝酸酯类一氧化氮(NO)供体设计成姜黄素前药衍生物;以姜黄素为起始原料,将其用二溴烷烃醚化合成得到姜黄素溴代烷基醚中间体,再将其与硝酸银反应成酯得到目标化合物姜黄素硝氧烷基酯衍生物;目标化合物经IR、1H-NMR和MS表征确证为硝酸酯类NO供体型姜黄素衍生物。硝酸酯类姜黄素衍生物的合成方法简便可行,可为进一步生物活性测试提供原料。 To search for more active antitumor drugs,curcumin and nitrate NO donor were designed as curcumin prodrug derivatives according to prodrug principle and conjugation principle.Curcumin is the starting material,the intermediates of curcumin bromide alkyl ether were synthesized by etherification with 2 bromo alkanes.Then it was reacted with silver nitrate to form esters to obtain curcuminnitryl alkyl ester derivatives.The target compound was confirmed to be nitrate NO donor curcumin derivatives by IR,1H-NMR and MS characterization.The synthetic method of curcumin derivatives of nitrate esters is simple and feasible,which can be used as raw materials for further bioassay.
作者 陈维珍 徐济恒 徐苏丽 CHEN Weizhen;XU Jiheng;XU Suli(Department of Medicine,Huangshan Vocational and Technical College,Huangshan 245000,China)
出处 《宿州学院学报》 2019年第9期77-80,共4页 Journal of Suzhou University
基金 安徽省高校科学研究项目(KJ2019H04) 安徽省高校优秀青年骨干人才国内访学研修项目(gxgnfx2018122)
关键词 NO供体 姜黄素 前药 姜黄素衍生物 NO donor Curcumin Prodrug Curcumin derivative
  • 相关文献

参考文献8

二级参考文献80

  • 1Wei HU Yan LI Chun Zhen ZHANG.Enantioseparation of Racemic Anti-hepatitis New Drug Bicyclol with Crystallization[J].Chinese Chemical Letters,2005,16(11):1471-1473. 被引量:2
  • 2彭景华,胡义扬.姜黄素抗肝损伤研究进展[J].国外医学(消化系疾病分册),2005,25(6):373-375. 被引量:19
  • 3何雅军,舒建昌,吕霞,方力,沈雁.姜黄素预防肝纤维化作用与肝星状细胞的关系[J].中华肝脏病杂志,2006,14(5):337-340. 被引量:37
  • 4牛培勤,郭传勇.白藜芦醇药理作用的研究进展[J].医药导报,2006,25(6):524-525. 被引量:79
  • 5STUEHR DJ, KWON NS, NATHAN CF, et al. NW-Hydroxy-L- arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine[J]. JBiol Chem, 1991, 26(10): 6259-6263.
  • 6RAO CV, REDDY BS, STEELE VE, et al. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects an molecular targets [J]. Mol Cancer Ther, 2006, 5(6) :1530-1538.
  • 7WALLACE JL, MUSCARA MN, DE NUCCI G, et al. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [ 3 - [ 4- ( 2 -Fluoro-α-methyl- [ 1, 1'-biphenyl ] -4-acetyloxy ) -3 -methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester I [J ]. J Pharmacol Exp Ther, 2004, 309 (2) :626 - 633.
  • 8BERNARDO A, GASPARINI L, ONGINI E, et al. Dynamic reg- ulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216 : implications for chronic treatments of neurodegenerative diseases [ J ]. Neurobiol Dis, 2006, 22 ( 1 ) :25 - 32.
  • 9BRUNELI,I S, SCIORATI C, D'ANTONA G, et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy[J]. Proc Natl Acad Sci USA, 2007, 104(1) :264 -269.
  • 10ABDUL-HAY SO, LUO J, ASHGHODOM RT, et al. NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade [ J ]. J Neurochem, 2009, 111 (3) :766 -776.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部